C9orf72 and frontotemporal dementia: Considering the specific genotypes, in the group of C9orf72 carriers (Figure 1A), 12/19 (63%) patients tested positive; specifically, two diagnosed with ALS, 1 with FTD‐ALS and 9 diagnosed with FTD.